FSA
PBYI icon

Franklin Street Advisors’s Puma Biotechnology PBYI Stock Holding History

Franklin Street Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,000
Closed -$459K – 159
2018
Q3 		$459K Sell
10,000
-10,000
-50% -$482K 0.06% 108
2018
Q2 		$1.18M Sell
20,000
-2,000
-9% -$116K 0.17% 72
2018
Q1 		$1.5M Hold
22,000
– – 0.22% 68
2017
Q4 		$2.17M Hold
22,000
– – 0.33% 67
2017
Q3 		$2.63M Sell
22,000
-1,000
-4% -$93K 0.43% 64
2017
Q2 		$2.01M Sell
23,000
-7,000
-23% -$392K 0.34% 66
2017
Q1 		$1.12M Buy
30,000
+1,000
+3% +$36.5K 0.2% 84
2016
Q4 		$890K Sell
29,000
-700
-2% -$30.3K 0.16% 99
2016
Q3 		$1.99M Sell
29,700
-4,325
-13% -$219K 0.36% 77
2016
Q2 		$1.01M Buy
34,025
+980
+3% +$30.6K 0.19% 102
2016
Q1 		$971K Buy
33,045
+18,300
+124% +$827K 0.19% 106
2015
Q4 		$1.16M Buy
14,745
+350
+2% +$27.5K 0.23% 107
2015
Q3 		$1.08M Buy
14,395
+1,845
+15% +$174K 0.22% 111
2015
Q2 		$1.47M Buy
12,550
+2,930
+30% +$531K 0.26% 95
2015
Q1 		$2.27M Sell
9,620
-10,135
-51% -$2.17M 0.42% 69
2014
Q4 		$3.74M Sell
19,755
-2,235
-10% -$496K 0.71% 45
2014
Q3 		$5.25M Sell
21,990
-985
-4% -$202K 1% 29
2014
Q2 		$1.52M Buy
22,975
+775
+3% +$55.1K 0.29% 82
2014
Q1 		$2.31M Sell
22,200
-6,150
-22% -$723K 0.46% 64
2013
Q4 		$2.94M Sell
28,350
-100
-0.4% -$5.87K 0.59% 50
2013
Q3 		$1.53M Sell
28,450
-2,500
-8% -$135K 0.34% 79
2013
Q2 		$1.37M Buy
+30,950
New +$1.09M 0.34% 78

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Franklin Street Advisors's PBYI Position: Q4 2018 in Review

Franklin Street Advisors sold out of Puma Biotechnology (PBYI) in Q4 2018, closing a stake of 10,000 shares — an estimated $459K sold.

Franklin Street Advisors first reported a position in PBYI in Q2 2013 and held it in 22 quarters. The position peaked at $5.25M in Q3 2014. 141 funds tracked by Wall St. Rank hold PBYI as of Q4 2018.

  • Franklin Street Advisors reported no remaining Puma Biotechnology position as of Q4 2018 after selling out during the quarter.
  • Franklin Street Advisors sold 10,000 Puma Biotechnology shares in Q4 2018, an estimated $459K.
  • Franklin Street Advisors first reported a position in Puma Biotechnology in Q2 2013 and held it in 22 quarters.
  • Franklin Street Advisors's Puma Biotechnology position peaked at $5.25M in Q3 2014.
  • 141 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2018.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.